Pathological diagnosis of hepatocellular adenoma in clinical practice

Diagnostic Histopathology

Volumn 17, Issue 12, 2011, Pages 521-529

  Bioulac Sage, Paulette ^a   Cubel, Gaelle ^a   Balabaud, Charles ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

catenin activated HCA (b HCA); Hepatocellular adenomas (HCA); HNF1 inactivated HCA (H HCA); Inflammatory HCA (IHCA)

Indexed keywords

ALBUMIN; BETA CATENIN; C REACTIVE PROTEIN; FATTY ACID; FATTY ACID BINDING PROTEIN; GLUTAMATE AMMONIA LIGASE; GLYCOGEN SYNTHASE KINASE 3BETA; GLYCOPROTEIN GP 130; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; INTERLEUKIN 6; SERUM AMYLOID A; STAT3 PROTEIN; TRYPSIN INHIBITOR;

ADENOMATOSIS; ARTICLE; CANCER SURGERY; CHROMOSOME 12Q; CLINICAL PRACTICE; FATTY ACID ANALYSIS; FATTY LIVER; GENOTYPE; GLYCOGEN STORAGE DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER ADENOMA; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER NODULE; MALIGNANT TRANSFORMATION; MORPHOLOGY; NODULAR HYPERPLASIA; OBESITY; PHENOTYPE; SIGNAL TRANSDUCTION; TUMOR CLASSIFICATION; TYROSINEMIA;

EID: 82955163286     PISSN: 17562317     EISSN: 18767621     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2011.10.007     Document Type: Article

References (27)

1. Bioulac-Sage P., Laumonier H., Couchy G., et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 2009, 50:481-489.
2. Bluteau O., Jeannot E., Bioulac-Sage P., et al. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet 2002, 32:312-315.
3. Zucman-Rossi J., Jeannot E., Nhieu J.T., et al. Genotype phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 2006, 43:515-524.
4. Rebouissou S., Amessou M., Couchy G., et al. Frequent inframe somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 2009, 457:200-204.
5. Bioulac-Sage P., Rebouissou S., Thomas C., et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 2007, 46:740-748.
6. Rebouissou S., Imbeaud S., Balabaud C., et al. HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate response element-binding protein (ChREBP) activation. J Biol Chem 2007, 282:14437-14446.
7. Pelletier L., Rebouissou S., Paris A., et al. Loss of HNF1a function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis. Hepatology 2010, 51:557-566.
8. Bacq Y., Jacquemin E., Balabaud C., et al. Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. Gastroenterology 2003, 125:1470-1475.
9. Amessou M., Poussin K., Couchy S., Rebuissou S., Zucman-Rossi J., Genthep Constitutively active gp130 mutants cause inflammatory adenomas in liver (IHCA): functional analysis and identification of Janus kinase 1 as a potential therapeutic target. J Hepatology (abstract) 2011, 54:S45-S60.
10. Pilati C., Amessou M., Bihl M.P., et al. Somatic mutations activating STAT3 in inflammatory hepatocellular adenomas. J Exp Med 2011, 208:1359-1366.
11. Nault JC, Fabre M, Couchy G, et al. GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation. J Hepatol in press.
12. Bioulac-Sage P., Balabaud C., Wanless I. Focal nodular hyperplasia and hepatocellular adenoma. Tumors of the digestive tract 2010, 198-204. World Health Organization, IARC, Lyon, France. F. Bosman, F. Carneiro, R. Hruban, N.D. Theise (Eds.).
13. Bioulac-Sage P., Laumonier H., Balabaud C. Benign hepatocellular tumors. Practical hepatic pathology 2010, chapter 34, p 473-488. R. Saxena (Ed.).
14. Bioulac-Sage P., Cubel G., Balabaud C., Zucman-Rossi J. Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers. Semin Liver Dis 2011, 31:91-103.
15. van Aalten S.M., Verheij J., Terkivatan T., Dwarkasing R.S., de Man R.A., Ijzermans J.N. Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice. J Hepatol 2011, 55:120-125.
16. Bioulac-Sage P., Laumonier H., Rullier A., et al. Overexpression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology. Liver Int 2009, 29:459-465.
17. Laumonier H., Bioulac-Sage P., Laurent C., Zucman-Rossi J., Balabaud C., Trillaud H. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 2008, 48:808-818.
18. Bioulac-Sage P., Rebouissou S., Sa Cunha A., et al. Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology 2005, 128:1211-1218.
19. Paradis V., Champault A., Ronot M., et al. Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. Hepatology 2007, 46:140-146.
20. Sa Cunha A., Blanc J.F., Lazaro E., et al. Inflammatory syndrome with liver adenomatosis: the beneficial effects of surgical management. Gut 2007, 56:307-309.
21. Cassiman D., Libbrecht L., Verslype C., et al. An adult male patient with multiple adenomas and a hepatocellular carcinoma: mild glycogen storage disease type Ia. J Hepatol 2010, 53:213-217.
22. Velazquez I., Alter B.P. Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions. Am J Hematol 2004, 77:257-267.
23. Toso C., Rubbia-Brandt L., Negro F., Morel P., Mentha G. Hepatocellular adenoma and polycystic ovary syndrome. Liver Int 2003, 23:35-37.
24. Watkins J., Balabaud C., Bioulac-Sage P., Sharma D., Dhillon A. Hepatocellular adenoma in advanced-stage fatty liver disease. Eur J Gastroenterol Hepatol 2009, 21:932-936.
25. Lepreux S., Laurent C., Blanc J.F., et al. The identification of small nodules in liver adenomatosis. J Hepatol 2003, 39:77-85.
26. Bioulac-Sage P., Laumonier H., Cubel G., Rossi J.Z., Balabaud C. Hepatic resection for inflammatory hepatocellular adenomas: pathological identification of micronodules expressing inflammatory proteins. Liver Int 2010, 30:149-154.
27. Bioulac-sage P., Cubel G., Letreutre E., et al. Biopsy of liver tumors: specific molecular markers helps to differentiate focal nodular hyperplasia from hepatocellular adenomas and allows the identification of hepatocellular adenomas subtypes. A French multicentric study. Hepatology (abstract) 2010, 52:1135A.